1. Home
  2. NICE vs STVN Comparison

NICE vs STVN Comparison

Compare NICE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$112.64

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.42

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
STVN
Founded
1986
1949
Country
Israel
Italy
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
5.4B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NICE
STVN
Price
$112.64
$19.42
Analyst Decision
Buy
Hold
Analyst Count
13
2
Target Price
$162.31
$23.75
AVG Volume (30 Days)
764.2K
294.8K
Earning Date
02-19-2026
03-05-2026
Dividend Yield
N/A
0.32%
EPS Growth
35.79
19.61
EPS
8.79
0.60
Revenue
$2,880,503,000.00
$1,373,219,524.00
Revenue This Year
$9.57
$8.42
Revenue Next Year
$8.07
$9.61
P/E Ratio
$12.77
$33.04
Revenue Growth
9.24
6.97
52 Week Low
$99.00
$17.81
52 Week High
$180.61
$28.00

Technical Indicators

Market Signals
Indicator
NICE
STVN
Relative Strength Index (RSI) 45.09 35.90
Support Level $114.35 $20.19
Resistance Level $117.87 $21.23
Average True Range (ATR) 3.17 0.76
MACD -0.16 -0.07
Stochastic Oscillator 33.85 8.13

Price Performance

Historical Comparison
NICE
STVN

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: